These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2859987

  • 1. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
    Waelbroeck M, Robberecht P, Coy DH, Camus JC, De Neef P, Christophe J.
    Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987
    [Abstract] [Full Text] [Related]

  • 2. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.
    Robberecht P, Coy DH, Waelbroeck M, Heiman ML, de Neef P, Camus JC, Christophe J.
    Endocrinology; 1985 Nov; 117(5):1759-64. PubMed ID: 2994998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.
    Moretti C, Bagnato A, Solan N, Frajese G, Catt KJ.
    Endocrinology; 1990 Nov 01; 127(5):2117-26. PubMed ID: 2171907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of antagonists of vasoactive intestinal peptide on nonadrenergic noncholinergic inhibitory responses in feline airways.
    Thompson DC, Altiere RJ, Diamond L.
    Peptides; 1988 Nov 01; 9(2):443-7. PubMed ID: 3131749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
    Grider JR, Rivier JR.
    J Pharmacol Exp Ther; 1990 May 01; 253(2):738-42. PubMed ID: 2110976
    [Abstract] [Full Text] [Related]

  • 16. Lack of effect of vasoactive intestinal peptide antagonists on blood flow in the rat thyroid.
    Michalkiewicz M, Huffman LJ, Hedge GA.
    Peptides; 1991 May 01; 12(6):1181-6. PubMed ID: 1815206
    [Abstract] [Full Text] [Related]

  • 17. An analogue of growth hormone releasing factor (GRF), (Ac-Try1, D-Phe2)-GRF-(1-29), specifically antagonizes the facilitation of the flexor reflex induced by intrathecal vasoactive intestinal peptide in rat spinal cord.
    Xu XJ, Wiesenfeld-Hallin Z.
    Neuropeptides; 1991 Mar 01; 18(3):129-35. PubMed ID: 2067598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A glucagon-secretin-like peptide stimulates the intrinsic nervous plexus of guinea pig gallbladder.
    Greco AV, Mancinelli R, Mingrone G, Racanicchi C.
    Experientia; 1990 May 15; 46(5):452-4. PubMed ID: 1971797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.